Security Snapshot

Alvotech - Ordinary Shares (ALVO) Institutional Ownership

CUSIP: L01800108

13F Institutional Holders and Ownership History from Q2 2022 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

70

Shares (Excl. Options)

42,513,945

Price

$3.69

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+25,833,340
Value change
+$95,444,092
Number of holders
70
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
390,730,865
SEC-reported price per share
$3.80
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ALVO - Alvotech - Ordinary Shares is tracked under CUSIP L01800108.
  • 70 institutions reported positions in Q2 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 53 to 70 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $56,702,299 to $157,434,435.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 70 institutions filings for Q2 2026.

Open SEC evidence

Security key

L01800108

Latest holder period

Q2 2026

13F holders

70

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
ALVO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Celtic Holdings SCA 28% $367,482,379 107,450,988 Celtic Holdings S.C.A. 26 Jun 2026
Aztiq Pharma Partners S.a r.l. 33% $533,786,019 103,849,420 Aztiq Pharma Partners S.a r.l. 17 Dec 2025

As of 30 Jun 2026, 70 institutional investors reported holding 42,513,945 shares of Alvotech - Ordinary Shares (ALVO). This represents 11% of the company’s total 390,730,865 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
11%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Rubric Capital Management LP 4% 15,677,093 0.53% $57,848,473
MILLENNIUM MANAGEMENT LLC 1.1% 4,263,644 +101% 0.01% $15,732,846
Bracebridge Capital, LLC 1% 4,038,637 +49% 3.2% $14,902,571
VANGUARD CAPITAL MANAGEMENT LLC 0.94% 3,689,612 +8.2% 0% $13,965,181
FARALLON CAPITAL MANAGEMENT, L.L.C. 0.73% 2,859,675 +1332% 0.06% $10,552,201
CITADEL ADVISORS LLC 0.44% 1,728,002 0% $6,376,328
PRICE T ROWE ASSOCIATES INC /MD/ 0.36% 1,418,392 +1.5% 0% $5,234,000
BlackRock, Inc. 0.34% 1,327,282 +6.6% 0% $4,897,671
LITTLEJOHN & CO LLC 0.34% 1,318,534 0% 6.2% $4,865,390
VANGUARD FIDUCIARY TRUST CO 0.26% 998,597 +2.5% 0% $3,779,690
Legal & General Group Plc 0.18% 696,048 +38% 0% $2,651,476
MORGAN STANLEY 0.17% 670,041 +175% 0% $2,472,451
ROYCE & ASSOCIATES LP 0.14% 558,144 0.02% $2,059,551
JPMORGAN CHASE & CO 0.14% 529,689 +5.1% 0% $1,970,443
SONA ASSET MANAGEMENT (US) LLC 0.09% 360,000 0.05% $1,328,400
GEODE CAPITAL MANAGEMENT, LLC 0.08% 297,261 -8.3% 0% $1,096,893
UBS Group AG 0.06% 253,482 -21% 0% $935,349
Hudson Bay Capital Management LP 0.06% 238,107 0% $878,615
VANGUARD ASSET MANAGEMENT, Ltd 0.04% 151,935 0% 0% $575,074
Lighthouse Investment Partners, LLC 0.03% 125,000 0.01% $461,250
Ulland Investment Advisors, LLC 0.03% 109,500 +12% 0.3% $404,000
OAKTREE CAPITAL MANAGEMENT LP 0.03% 97,982 0% 0.01% $361,553
Invesco Ltd. 0.02% 90,477 +15% 0% $333,860
Savant Capital, LLC 0.02% 83,732 +7.6% 0% $308,972
STIFEL FINANCIAL CORP 0.02% 78,951 +85% 0% $291,330

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
17
Latest
Q2 2026
Rows shown
1-17 of 17
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 42,513,945 $157,434,435 +$95,444,092 $3.69 70
2026 Q1 16,506,414 $56,702,299 +$3,405,430 $3.43 53
2025 Q4 15,527,894 $78,052,031 -$1,136,717 $5.13 48
2025 Q3 15,616,027 $127,787,483 -$23,088,302 $8.19 64
2025 Q2 17,039,963 $155,800,629 +$5,013,997 $9.12 51
2025 Q1 16,466,684 $158,801,696 +$14,857,882 $9.67 49
2024 Q4 15,209,918 $199,269,907 +$3,473,265 $13.23 44
2024 Q3 14,991,393 $177,990,036 +$13,702,862 $11.90 31
2024 Q2 13,787,759 $167,164,357 +$3,525,463 $12.16 29
2024 Q1 13,458,693 $164,634,428 -$39,286,607 $12.22 20
2023 Q4 16,791,901 $192,815,783 -$1,109,006 $11.48 17
2023 Q3 17,081,113 $155,823,907 +$3,190,655 $9.12 18
2023 Q2 16,799,973 $130,224,317 -$11,628,070 $7.74 16
2023 Q1 18,955,901 $244,613,904 +$2,723,422 $12.90 17
2022 Q4 18,747,770 $184,711,213 -$11,915,244 $10.00 11
2022 Q3 20,765,078 $140,565,000 +$9,057,505 $6.76 14
2022 Q2 19,414,528 $157,758,000 +$157,758,000 $8.21 17
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .